{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:38:57Z","timestamp":1786552737295,"version":"3.56.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"DOI":"10.1038\/s41586-026-10909-6","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:02:10Z","timestamp":1786546930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucose-responsive probiotics for glycaemic modulation in mice and monkeys"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6174-8053","authenticated-orcid":false,"given":"Ningzi","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqiang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxue","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-6321","authenticated-orcid":false,"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9209-8206","authenticated-orcid":false,"given":"Shangang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5482-8116","authenticated-orcid":false,"given":"Haifeng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"10909_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","volume":"21","author":"CJ Bashor","year":"2022","unstructured":"Bashor, C. J., Hilton, I. B., Bandukwala, H., Smith, D. M. & Veiseh, O. Engineering the next generation of cell-based therapeutics. Nat. Rev. Drug Discov. 21, 655\u2013675 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10909_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41587-021-01036-w","volume":"40","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. A small and highly sensitive red\/far-red optogenetic switch for applications in mammals. Nat. Biotechnol. 40, 262\u2013272 (2022).","journal-title":"Nat. Biotechnol."},{"key":"10909_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.aaf4006","volume":"354","author":"M Xie","year":"2016","unstructured":"Xie, M. et al. \u03b2-cell-mimetic designer cells provide closed-loop glycemic control. Science 354, 1296\u20131301 (2016).","journal-title":"Science"},{"key":"10909_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden, M. & Shulman, G. I. The integrative biology of type 2 diabetes. Nature 576, 51\u201360 (2019).","journal-title":"Nature"},{"key":"10909_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69\u201382 (2014).","journal-title":"Lancet"},{"key":"10909_CR6","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee, S., Khunti, K. & Davies, M. J. Type 2 diabetes. Lancet 389, 2239\u20132251 (2017).","journal-title":"Lancet"},{"key":"10909_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fendo.2017.00006","volume":"8","author":"A Chaudhury","year":"2017","unstructured":"Chaudhury, A. et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front. Endocrinol. 8, 6 (2017).","journal-title":"Front. Endocrinol."},{"key":"10909_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","volume":"398","author":"J Rosenstock","year":"2021","unstructured":"Rosenstock, J. et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet 398, 143\u2013155 (2021).","journal-title":"Lancet"},{"key":"10909_CR9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1056\/NEJMp1001578","volume":"362","author":"M Parks","year":"2010","unstructured":"Parks, M. & Rosebraugh, C. Weighing risks and benefits of liraglutide\u2013the FDA\u2019s review of a new antidiabetic therapy. N. Engl. J. Med. 362, 774\u2013777 (2010).","journal-title":"N. Engl. J. Med."},{"key":"10909_CR10","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/jama.2018.3024","volume":"319","author":"SL Zheng","year":"2018","unstructured":"Zheng, S. L. et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA 319, 1580\u20131591 (2018).","journal-title":"JAMA"},{"key":"10909_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","volume":"173","author":"S Singh","year":"2013","unstructured":"Singh, S. et al. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern. Med. 173, 534\u2013539 (2013).","journal-title":"JAMA Intern. Med."},{"key":"10909_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca, F. W. et al. Generation of functional human pancreatic \u03b2 cells in vitro. Cell 159, 428\u2013439 (2014).","journal-title":"Cell"},{"key":"10909_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41573-021-00285-3","volume":"20","author":"A Cubillos-Ruiz","year":"2021","unstructured":"Cubillos-Ruiz, A. et al. Engineering living therapeutics with synthetic biology. Nat. Rev. Drug Discov. 20, 941\u2013960 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10909_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nbt.3879","volume":"35","author":"DT Riglar","year":"2017","unstructured":"Riglar, D. T. et al. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation. Nat. Biotechnol. 35, 653\u2013658 (2017).","journal-title":"Nat. Biotechnol."},{"key":"10909_CR15","doi-asserted-by":"publisher","first-page":"289ra283","DOI":"10.1126\/scitranslmed.aaa3601","volume":"7","author":"A Courbet","year":"2015","unstructured":"Courbet, A., Endy, D., Renard, E., Molina, F. & Bonnet, J. Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates. Sci. Transl. Med. 7, 289ra283 (2015).","journal-title":"Sci. Transl. Med."},{"key":"10909_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"VM Isabella","year":"2018","unstructured":"Isabella, V. M. et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat. Biotechnol. 36, 857\u2013864 (2018).","journal-title":"Nat. Biotechnol."},{"key":"10909_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102379","volume":"6","author":"X Gao","year":"2025","unstructured":"Gao, X. et al. Designer probiotic-based living drugs for uric acid homeostasis control in hyperuricemic mice and rats. Cell Rep. Med. 6, 102379 (2025).","journal-title":"Cell Rep. Med."},{"key":"10909_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2026.03.048","author":"N Aggarwal","year":"2026","unstructured":"Aggarwal, N. et al. Engineered commensals for metabolic modulation of the gut\u2013liver\u2013brain axis. Cell https:\/\/doi.org\/10.1016\/j.cell.2026.03.048 (2026).","journal-title":"Cell"},{"key":"10909_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.tibtech.2018.09.005","volume":"37","author":"DB Pedrolli","year":"2019","unstructured":"Pedrolli, D. B., Ribeiro, N. V., Squizato, P. N., de Jesus, V. N. & Cozetto, D. A. Engineering microbial living therapeutics: the synthetic biology toolbox. Trends Biotechnol. 37, 100\u2013115 (2019).","journal-title":"Trends Biotechnol."},{"key":"10909_CR20","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1099\/mic.0.2008\/020362-0","volume":"154","author":"J Kim","year":"2008","unstructured":"Kim, J., Jeon, C. O. & Park, W. Dual regulation of zwf-1 by both 2-keto-3-deoxy-6-phosphogluconate and oxidative stress in Pseudomonas putida. Microbiology 154, 3905\u20133916 (2008).","journal-title":"Microbiology"},{"key":"10909_CR21","doi-asserted-by":"publisher","first-page":"21360","DOI":"10.1074\/jbc.M109.014555","volume":"284","author":"A Daddaoua","year":"2009","unstructured":"Daddaoua, A., Krell, T. & Ramos, J. L. Regulation of glucose metabolism in Pseudomonas: the phosphorylative branch and entner-doudoroff enzymes are regulated by a repressor containing a sugar isomerase domain. J. Biol. Chem. 284, 21360\u201321368 (2009).","journal-title":"J. Biol. Chem."},{"key":"10909_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1370","author":"MM Meyer","year":"2017","unstructured":"Meyer, M. M. The role of mRNA structure in bacterial translational regulation. WIREs RNA https:\/\/doi.org\/10.1002\/wrna.1370 (2017).","journal-title":"WIREs RNA"},{"key":"10909_CR23","first-page":"103","volume":"93","author":"K Pippitt","year":"2016","unstructured":"Pippitt, K., Li, M. & Gurgle, H. E. Diabetes mellitus: screening and diagnosis. Am. Fam. Physician 93, 103\u2013109 (2016).","journal-title":"Am. Fam. Physician"},{"key":"10909_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35074-y","volume":"13","author":"E De la Paz","year":"2022","unstructured":"De la Paz, E. et al. A self-powered ingestible wireless biosensing system for real-time in situ monitoring of gastrointestinal tract metabolites. Nat. Commun. 13, 7405 (2022).","journal-title":"Nat. Commun."},{"key":"10909_CR25","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203535","volume":"332","author":"H Ye","year":"2011","unstructured":"Ye, H., Daoud-El Baba, M., Peng, R.-W. & Fussenegger, M. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 332, 1565\u20131568 (2011).","journal-title":"Science"},{"key":"10909_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/187220810790069550","volume":"4","author":"SH Yoon","year":"2010","unstructured":"Yoon, S. H., Kim, S. K. & Kim, J. F. Secretory production of recombinant proteins in Escherichia coli. Recent Pat. Biotechnol. 4, 23\u201329 (2010).","journal-title":"Recent Pat. Biotechnol."},{"key":"10909_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1476-5381.2011.01687.x","volume":"166","author":"D Donnelly","year":"2012","unstructured":"Donnelly, D. The structure and function of the glucagon-like peptide-1 receptor and its ligands. Br. J. Pharmacol. 166, 27\u201341 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"10909_CR28","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1016\/j.cell.2022.05.007","volume":"185","author":"T Zhang","year":"2022","unstructured":"Zhang, T., Perkins, M. H., Chang, H., Han, W. & de Araujo, I. E. An inter-organ neural circuit for appetite suppression. Cell 185, 2478\u20132494.e2428 (2022).","journal-title":"Cell"},{"key":"10909_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff, A. M. et al. Tirzepatide once weekly for the treatment of obesity. N. Engl. J. Med. 387, 205\u2013216 (2022).","journal-title":"N. Engl. J. Med."},{"key":"10909_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","volume":"3","author":"MQ Ludwig","year":"2021","unstructured":"Ludwig, M. Q. et al. A genetic map of the mouse dorsal vagal complex and its role in obesity. Nat. Metab. 3, 530\u2013545 (2021).","journal-title":"Nat. Metab."},{"key":"10909_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase, D. M. et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J. Diabetes Res. 2020, 3920196 (2020).","journal-title":"J. Diabetes Res."},{"key":"10909_CR32","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.3748\/wjg.v20.i13.3507","volume":"20","author":"G Maconi","year":"2014","unstructured":"Maconi, G. et al. Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implications. World J. Gastroenterol. 20, 3507\u20133515 (2014).","journal-title":"World J. Gastroenterol."},{"key":"10909_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/1753-0407.12986","volume":"12","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression. J. Diabetes 12, 224\u2013236 (2020).","journal-title":"J. Diabetes"},{"key":"10909_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan, Y. et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575, 505\u2013511 (2019).","journal-title":"Nature"},{"key":"10909_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0510-8","volume":"6","author":"S Just","year":"2018","unstructured":"Just, S. et al. The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism. Microbiome 6, 134 (2018).","journal-title":"Microbiome"},{"key":"10909_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.chom.2019.06.013","volume":"26","author":"JE Bisanz","year":"2019","unstructured":"Bisanz, J. E., Upadhyay, V., Turnbaugh, J. A., Ly, K. & Turnbaugh, P. J. Meta-analysis reveals reproducible gut microbiome alterations in response to a high-fat diet. Cell Host Microbe 26, 265\u2013272.e264 (2019).","journal-title":"Cell Host Microbe"},{"key":"10909_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1219763","volume":"14","author":"J Shi","year":"2023","unstructured":"Shi, J. et al. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice. Front. Microbiol. 14, 1219763 (2023).","journal-title":"Front. Microbiol."},{"key":"10909_CR38","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","volume":"390","author":"MN Kosiborod","year":"2024","unstructured":"Kosiborod, M. N. et al. Semaglutide in patients with obesity-related heart failure and type 2 diabetes. N. Engl. J. Med. 390, 1394\u20131407 (2024).","journal-title":"N. Engl. J. Med."},{"key":"10909_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1463-1326.2012.01560.x","volume":"14","author":"MS Fineman","year":"2012","unstructured":"Fineman, M. S., Cirincione, B. B., Maggs, D. & Diamant, M. GLP-1 based therapies: differential effects on fasting and postprandial glucose. Diabetes Obes. Metab. 14, 675\u2013688 (2012).","journal-title":"Diabetes Obes. Metab."},{"key":"10909_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.595575","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Engineered bacteria of MG1363\u2013pMG36e\u2013GLP-1 attenuated obesity-induced by high fat diet in mice. Front. Cell. Infect. Microbiol. 11, 595575 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10909_CR41","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1007\/s11095-014-1430-3","volume":"31","author":"P Agarwal","year":"2014","unstructured":"Agarwal, P., Khatri, P., Billack, B., Low, W. K. & Shao, J. Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis. Pharm. Res. 31, 3404\u20133414 (2014).","journal-title":"Pharm. Res."},{"key":"10909_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12934-024-02370-9","volume":"23","author":"S Snoeck","year":"2024","unstructured":"Snoeck, S., Guidi, C. & De Mey, M. \u201cMetabolic burden\u201d\u00a0explained: stress symptoms and its related responses induced by (over)expression of (heterologous) proteins in Escherichia coli. Microb. Cell Fact. 23, 96 (2024).","journal-title":"Microb. Cell Fact."},{"key":"10909_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4093\/dmj.2025.0242","volume":"49","author":"JA Kim","year":"2025","unstructured":"Kim, J. A. & Yoo, H. J. Exploring the side effects of GLP-1 receptor agonist: to ensure its optimal positioning. Diabetes Metab. J. 49, 525\u2013541 (2025).","journal-title":"Diabetes Metab. J."},{"key":"10909_CR44","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/bph.15611","volume":"179","author":"JJ Holst","year":"2022","unstructured":"Holst, J. J., Andersen, D. B. & Grunddal, K. V. Actions of glucagon-like peptide-1 receptor ligands in the gut. Br. J. Pharmacol. 179, 727\u2013742 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"10909_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/jci194744","author":"LR Beutler","year":"2026","unstructured":"Beutler, L. R. GLP-1 physiology and pharmacology along the gut\u2013brain axis. JCI https:\/\/doi.org\/10.1172\/jci194744 (2026).","journal-title":"JCI"},{"key":"10909_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbpa.2017.04.011","volume":"40","author":"KJ Chua","year":"2017","unstructured":"Chua, K. J., Kwok, W. C., Aggarwal, N., Sun, T. & Chang, M. W. Designer probiotics for the prevention and treatment of human diseases. Curr. Opin. Chem. Biol. 40, 8\u201316 (2017).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10909_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004529","volume":"32","author":"DW Zheng","year":"2020","unstructured":"Zheng, D. W. et al. Prebiotics-encapsulated probiotic spores regulate gut microbiota and suppress colon cancer. Adv. Mater. 32, e2004529 (2020).","journal-title":"Adv. Mater."},{"key":"10909_CR48","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41579-021-00667-9","volume":"20","author":"MT Sorbara","year":"2022","unstructured":"Sorbara, M. T. & Pamer, E. G. Microbiome-based therapeutics. Nat. Rev. Microbiol. 20, 365\u2013380 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"10909_CR49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1538\/expanim.24-0154","volume":"74","author":"K Miyazaki","year":"2025","unstructured":"Miyazaki, K. et al. The usefulness of HbA1c measurement in diabetic mouse models using various devices. Exp. Anim. 74, 319\u2013327 (2025).","journal-title":"Exp. Anim."},{"key":"10909_CR50","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1127059","volume":"313","author":"JP Nougayr\u00e8de","year":"2006","unstructured":"Nougayr\u00e8de, J. P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848\u2013851 (2006).","journal-title":"Science"},{"key":"10909_CR51","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41396-018-0068-2","volume":"12","author":"C Serena","year":"2018","unstructured":"Serena, C. et al. Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 12, 1642\u20131657 (2018).","journal-title":"ISME J."},{"key":"10909_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12206670","author":"AR Bourgonje","year":"2023","unstructured":"Bourgonje, A. R., Connelly, M. A., van Goor, H., van Dijk, P. R. & Dullaart, R. P. F. Plasma citrate levels are associated with an increased risk of cardiovascular mortality in patients with type 2 diabetes (Zodiac-64). J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm12206670 (2023).","journal-title":"J. Clin. Med."},{"key":"10909_CR53","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jcp.15.6.579","volume":"15","author":"J Landon","year":"1962","unstructured":"Landon, J., Fawcett, J. K. & Wynn, V. Blood pyruvate concentration measured by a specific method in control subjects. J. Clin. Pathol. 15, 579\u2013584 (1962).","journal-title":"J. Clin. Pathol."},{"key":"10909_CR54","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1128\/AEM.00508-07","volume":"73","author":"A Belenguer","year":"2007","unstructured":"Belenguer, A. et al. Impact of pH on lactate formation and utilization by human fecal microbial communities. Appl. Environ. Microbiol. 73, 6526\u20136533 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"10909_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2165\/00007256-199826030-00002","volume":"26","author":"RA Robergs","year":"1998","unstructured":"Robergs, R. A. & Griffin, S. E. Glycerol. Biochemistry, pharmacokinetics and clinical and practical applications. Sports Med. 26, 145\u2013167 (1998).","journal-title":"Sports Med."},{"key":"10909_CR56","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/anatox\/35.9.617","volume":"35","author":"JL Nelson","year":"2011","unstructured":"Nelson, J. L., Harmon, M. E. & Robergs, R. A. Identifying plasma glycerol concentration associated with urinary glycerol excretion in trained humans. J. Anal. Toxicol. 35, 617\u2013623 (2011).","journal-title":"J. Anal. Toxicol."},{"key":"10909_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010094","author":"B Merino","year":"2019","unstructured":"Merino, B., Fern\u00e1ndez-D\u00edaz, C. M., C\u00f3zar-Castellano, I. & Perdomo, G. Intestinal fructose and glucose metabolism in health and disease. Nutrients https:\/\/doi.org\/10.3390\/nu12010094 (2019).","journal-title":"Nutrients"},{"key":"10909_CR58","unstructured":"Berry, G. T. Classic galactosemia and clinical variant galactosemia. GeneReviews https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1518\/ (2021)."},{"key":"10909_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2022.137204","volume":"446","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. An oral \u201csuper probiotics\u201d with versatile self-assembly adventitia for enhanced intestinal colonization by autonomous regulating the pathological microenvironment. Chem. Eng. J. 446, 137204 (2022).","journal-title":"Chem. Eng. J."},{"key":"10909_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101675","volume":"69","author":"F Long","year":"2023","unstructured":"Long, F. et al. A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice. Mol. Metab. 69, 101675 (2023).","journal-title":"Mol. Metab."},{"key":"10909_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/416254","volume":"2011","author":"ER Gilbert","year":"2011","unstructured":"Gilbert, E. R., Fu, Z. & Liu, D. Development of a nongenetic mouse model of type 2 diabetes. Exp. Diabetes Res. 2011, 416254 (2011).","journal-title":"Exp. Diabetes Res."},{"key":"10909_CR62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S2213-8587(23)00388-1","volume":"12","author":"Y Mu","year":"2024","unstructured":"Mu, Y. et al. Efficacy and safety of once weekly semaglutide 2.4\u2009mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 12, 184\u2013195 (2024).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10909_CR63","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1126\/science.122.3160.157","volume":"122","author":"J Garcia","year":"1955","unstructured":"Garcia, J., Kimeldorf, D. J. & Koelling, R. A. Conditioned aversion to saccharin resulting from exposure to gamma radiation. Science 122, 157\u2013158 (1955).","journal-title":"Science"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10909-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:50:18Z","timestamp":1786549818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10909-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":63,"alternative-id":["10909"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10909-6","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.Y., N.G. and X.G. are inventors on patent applications submitted by East China Normal University that cover the new glucose sensor, including a Chinese patent application (202210326236.9) and a Patent Cooperation Treaty application (PCT\/CN2023\/081232), which has entered the national phase in the USA (application no. 18\/852,503) and Europe (application no. 23777819.6). The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}